Publications by authors named "Shishen Sun"

Claim this Profile
M
ML385 increases ferroptosis via inhibiting Nrf2/HO-1 pathway to enhances the sensitivity of MCF-7 TAMR to tamoxifen.
Jie Yuan, Wenjun Huang, Minxia Lin, Shishen Sun, Fei Zhong

Naunyn Schmiedebergs Arch Pharmacol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Patient tissue-derived FGFR4-variant and wild-type colorectal cancer organoid development and anticancer drug sensitivity testing" [Heliyon Vol 10, Iss 10, May 2024, Article e30985].
Hailing Lin, Hongbo Fu, Shishen Sun, Hao Yin, Jie Yuan

Heliyon· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient tissue-derived FGFR4-variant and wild-type colorectal cancer organoid development and anticancer drug sensitivity testing.
Hailing Lin, Hongbo Fu, Shishen Sun, Hao Yin, Jie Yuan

Heliyon· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of baricitinib in patients with severe COVID-19: A systematic review and meta-analysis.
Wenxin Song, Shishen Sun, Yilong Feng, Liujun Liu, Tianqi Gao

Medicine (Baltimore)· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Involvement of RFC3 in tamoxifen resistance in ER-positive breast cancer through the cell cycle.
Jintao Zhu, Lei Ye, Shishen Sun, Jie Yuan, Jianfeng Huang

Aging (Albany NY)· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tamoxifen induces ferroptosis in MCF-7 organoid.
Lei Ye, Fei Zhong, Shishen Sun, Xiaowei Ou, Jie Yuan

J Cancer Res Ther· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis